Larson Financial Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.98K Sell
427
-32
-7% -$431 ﹤0.01% 2509
2025
Q4
$5.16K Buy
459
+255
+125% +$2.92K ﹤0.01% 2448
2025
Q3
$2.36K Sell
204
-20
-9% -$234 ﹤0.01% 2640
2025
Q2
$2.74K Buy
224
+34
+18% +$428 ﹤0.01% 2305
2025
Q1
$2.72K Hold
190
﹤0.01% 2071
2024
Q4
$3.02K Hold
190
﹤0.01% 1786
2024
Q3
$4.57K Sell
190
-18
-9% -$411 ﹤0.01% 1688
2024
Q2
$4.14K Buy
208
+204
+5,100% +$3.97K ﹤0.01% 1480
2024
Q1
$80 Hold
4
﹤0.01% 1721
2023
Q4
$90 Hold
4
﹤0.01% 1721
2023
Q3
$81 Hold
4
﹤0.01% 1665
2023
Q2
$102 Hold
4
﹤0.01% 1521
2023
Q1
$119 Hold
4
﹤0.01% 1490
2022
Q4
$108 Hold
4
﹤0.01% 1454
2022
Q3
$0 Hold
4
﹤0.01% 1293
2022
Q2
$0 Hold
4
﹤0.01% 1186
2022
Q1
$0 Hold
4
﹤0.01% 1039
2021
Q4
$0 Hold
4
﹤0.01% 1069
2021
Q3
$0 Hold
4
﹤0.01% 876
2021
Q2
$0 Hold
4
﹤0.01% 823
2021
Q1
$0 Hold
4
﹤0.01% 826
2020
Q4
$0 Hold
4
﹤0.01% 753
2020
Q3
$0 Hold
4
﹤0.01% 725
2020
Q2
$0 Hold
4
﹤0.01% 684
2020
Q1
$0 Hold
4
﹤0.01% 538
2019
Q4
$0 Hold
4
﹤0.01% 576
2019
Q3
$0 Hold
4
﹤0.01% 546
2019
Q2
$0 Hold
4
﹤0.01% 498
2019
Q1
$0 Hold
4
﹤0.01% 495
2018
Q4
$0 Buy
+4
New +$210 ﹤0.01% 474

Other funds holding AVNS

Larson Financial Group's AVNS Position: Q1 2026 in Review

Larson Financial Group reduced its Avanos Medical (AVNS) stake by 7% in Q1 2026, selling an estimated $431 and leaving 427 shares worth $5.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2509.

Larson Financial Group first reported a position in AVNS in Q4 2018 and has held it in 30 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Larson Financial Group held 427 shares of Avanos Medical worth $5.98K as of Q1 2026.
  • Larson Financial Group sold 32 Avanos Medical shares in Q1 2026, an estimated $431.
  • Avanos Medical made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #2509 holding.
  • Larson Financial Group first reported a position in Avanos Medical in Q4 2018 and has held it in 30 quarters since.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.